Our
Team

Integris Medtech is a diversified, India-based global medical products and laboratory solutions company, committed to transforming healthcare with expertise in developing, manufacturing, commercialising and selling a broad and integrated portfolio of medical devices and solutions. With operations spanning over 65 countries and manufacturing facilities in India, Germany, and the Netherlands, we deliver advanced cardiovascular devices, clinical diagnostics, and scientific laboratory solutions to over 2000 hospitals and cathlabs and more than 18,000 laboratories.

We deliver an integrated suite of technologies and solutions spanning the entire healthcare value chain from research and discovery, through disease diagnosis, to treatment. Our offerings support customers ranging from research laboratories working on new drug development, to clinical laboratories focusing on timely patient diagnosis, and hospitals providing advanced cardiovascular and therapeutic care.

Integris Medtech operates across two business segments, cardiovascular and laboratory solutions.

• Cardiovascular: We offer one of the most comprehensive portfolios across access, assess, prepare and treat in interventional cardiology, including drug-eluting stents (DES), drug-coated balloons (DCB), complex coronary intervention products, and vascular access solutions. Our products are backed by robust clinical evidence, including 10-year follow-up data on key DES platforms.

• Laboratory Solutions: As Southeast Asia’s largest lab solutions provider, we support over 18,000 laboratories and holds a presence in both clinical diagnostics and scientific lab settings. Our offerings span across life sciences, and industrial applications, complemented by calibration services and technical support.

Our integrated R&D and manufacturing capabilities enable effective transition from product concept to market launch. We are pioneers in introducing advanced therapies such as polymer-free stents and drug coated balloons (DCBs) with multi-layer coatings and advanced folding patterns and we continue to invest in clinical trials and real-world registries to validate our innovations.